Key result
Higher serum PUFAs are linked to lower T2DM prevalence, while specific MUFAs show positive association.
Why the study?
The role of serum fatty acids in Type 2 diabetes mellitus remains unclear, necessitating assessment of their associations with T2DM prevalence.
Are serum levels of specific unsaturated fatty acids associated with the prevalence of Type 2 diabetes mellitus?
Cross-Sectional (n=3,760)
Are serum levels of specific unsaturated fatty acids associated with the prevalence of Type 2 diabetes mellitus?
Answers are grounded in this paper and cite their sources.
Specific serum n-3 and n-6 PUFAs are inversely associated with T2DM prevalence, while certain n-9 MUFAs are positively associated, highlighting the heterogeneous metabolic effects of individual fatty acid species.
Objective The role of serum fatty acids in Type 2 diabetes mellitus (T2DM) remains unclear. We aimed to assess and compare the associations of multiple serum unsaturated fatty acids with the prevalence of T2DM to elucidate their heterogeneous relationship profiles. Methods This study used the data from the National Health and Nutrition Examination Surveys (2003–2004 and 2011–2012). Weighted proportional and multivariate logistic regression analyses were conducted to evaluate the associations of serum polyunsaturated fatty acids (PUFAs) and monounsaturated fatty acids (MUFAs) with T2DM status and to adjust for potential confounders. Results The study included 3760 individuals. Results of the multivariate logistic regression analyses showed that among the serum PUFAs, docosapentaenoic acid (DPAn3) (22:5 n3) was associated with lower odds of T2DM (odds ratio [OR]: 0.595, 95% CI: 0.375–0.942, P trend = 0.028). Arachidonic acid (AA) (20:4(20: 4 n6) and linoleic acid (LA) (18:2 n6) were negatively associated with T2DM prevalence (OR in quintile 5: AA [20:4 n6] = 0.396, 95% CI: 0.232–0.674, P trend = 0.002; LA (18:2 n6) = 0.277, 95% CI: 0.163–0.472, P trend < 0.001). Moreover, among the MUFAs, oleic acid (OA) (18:1 n9) and eicosenoic acid (EA) (20:1 n9) were associated with increased odds of T2DM, whereas nervonic acid (NRA) (24:1 n9) was associated with decreased odds of T2DM. Furthermore, nonlinear analyses showed that the n‐6 PUFAs dihomo‐ γ ‐linolenic acid (DGLA) (20:3 n6) and AA (20:4 n6), as well as the n‐9 MUFA EA (20:1 n9), had nonlinear associations with T2DM. Conclusions Our findings suggest that several serum n‐3 and n‐6 PUFAs are inversely associated with T2DM prevalence, whereas some n‐9 MUFAs are positively associated with T2DM prevalence. These findings provide comprehensive descriptive data on the serum fatty acid profile in relation to T2DM and underscore the heterogeneity of associations across individual fatty acid species.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a cross-sectional in Type 2 diabetes mellitus (n=3,760). Serum unsaturated fatty acids vs. Lower levels of serum fatty acids was evaluated on Type 2 diabetes mellitus status (OR 0.595, 95% CI 0.375-0.942, p=0.028). Higher serum levels of polyunsaturated fatty acids, including docosapentaenoic acid, were inversely associated with Type 2 diabetes mellitus prevalence.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: